Kuo Sheng-Fong, Chuang Wen-Yu, Ng Sohching, Chen Chih-Hung, Chang Chen-Nen, Chou Chi-Hsiang, Weng Wei-Chieh, Yeh Chih-Hua, Lin Jen-Der
J Pediatr Endocrinol Metab. 2013;26(9-10):945-8. doi: 10.1515/jpem-2013-0136.
Hyperglycemia is seldom described in young patients with pituitary gigantism. Here, we describe the case of a 17-year-old Taiwanese boy who developed depressive mood disorder and diabetic ketoacidosis (DKA) at the presentation of pituitary gigantism. The boy complained of lethargy and dysphoric mood in June 2008. He presented at the emergency department with epigastralgia and dyspnea in January 2009. Results of laboratory tests suggested type 1 diabetes mellitus with DKA. However, serum C-peptide level was normal on follow-up. Although he had no obvious features of acral enlargement, a high level of insulin-like growth factor 1 was detected, and a 75 g oral glucose suppression test showed no suppression of serum growth hormone levels. A pituitary macroadenoma was found on subsequent magnetic resonance imaging. The pituitary adenoma was surgically removed, followed by gamma-knife radiosurgery, and Sandostatin long-acting release treatment. He was then administered metformin, 500 mg twice daily, and to date, his serum glycohemoglobin has been <7%.
垂体巨人症的年轻患者中很少描述有高血糖情况。在此,我们描述一名17岁台湾男孩的病例,他在垂体巨人症发病时出现了抑郁情绪障碍和糖尿病酮症酸中毒(DKA)。该男孩在2008年6月主诉嗜睡和烦躁情绪。2009年1月他因上腹部疼痛和呼吸困难就诊于急诊科。实验室检查结果提示1型糖尿病合并DKA。然而,随访时血清C肽水平正常。尽管他没有明显的肢端肥大特征,但检测到高水平的胰岛素样生长因子1,并且75克口服葡萄糖抑制试验显示血清生长激素水平未被抑制。随后的磁共振成像发现了垂体大腺瘤。垂体腺瘤经手术切除,随后进行伽玛刀放射外科治疗以及长效善龙治疗。然后给他服用二甲双胍,每日两次,每次500毫克,迄今为止,他的糖化血红蛋白水平一直<7%。